The Andy Hill Cancer Research Endowment, a public-private partnership known as the CARE Fund, this week named Dr. Lucas Sullivan of Fred Hutchinson Cancer Research Center a CARE Fund Distinguished Researcher. The honor came with a $500,000 grant to further Sullivan’s research into the role of cell metabolism in cancer biology.
“His research into cancer metabolomics is highly significant, innovative and timely, and likely to have broad impacts in multiple fields, including cancer biology … and therapeutic developments that target metabolism,” the CARE Fund stated on its website.
Sullivan and colleagues seek to understand how metabolism supports cell function. Their major focus is to identify the metabolic pathways that are required for cancer growth and progression, with the goal of identifying new targets for cancer therapy.
